Product Information

OLANZAPINE-FLUOXETINE 3-25 MG is a generic product labeled by Endo USA Inc., priced at $3.6556 per EA under NDC 49884027711. Its NADAC has been published 626 times since Nov 28, 2013.

FDA first approved this application on Nov 2, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLANZAPINE-FLUOXETINE 3-25 MG

olanzapine and fuoxetine
$3.6556per EA

Strength

25; 3 mg/1; mg/1

Manufacturer

Endo USA Inc.

NDC

49884027711

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA077742

FDA Approved

11/2/2012

TE Code

AB

On Market Since

11/26/2012

Pharmacological Classes

Price Statistics

The NADAC for OLANZAPINE-FLUOXETINE 3-25 MG has been published 626 times since Nov 28, 2013, and over the history we have for it it has declined 49.4%. The table below summarizes its recorded NADAC range and movement.

Current price$3.6556 per EA
All-time high$8.3904 (Nov 12, 2014)
All-time low$3.1040 (Aug 23, 2023)
52-week high$3.9971
52-week low$3.6556
Median price$5.2743
Average price$5.4602
Largest weekly change+39.1% (Mar 23, 2022)
Weeks tracked626
Tracking sinceNov 28, 2013

Price History

1W

-5.4%

1M

-5.4%

3M

-7.9%

6M

-2.2%

1Y

-3.1%

3Y

-23.8%

5Y

-3.6%

All

-49.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the olanzapine and fuoxetine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of OLANZAPINE-FLUOXETINE 3-25 MG?

The current National Average Drug Acquisition Cost (NADAC) for OLANZAPINE-FLUOXETINE 3-25 MG, manufactured by Endo USA Inc., is $3.6556 per EA (NDC 49884027711), effective Aug 19, 2026.

How has the price of OLANZAPINE-FLUOXETINE 3-25 MG changed over time?

Over the history we have for it, the NADAC for OLANZAPINE-FLUOXETINE 3-25 MG has declined 49.4%. It has been tracked across 626 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for OLANZAPINE-FLUOXETINE 3-25 MG?

Since Nov 28, 2013, the NADAC for OLANZAPINE-FLUOXETINE 3-25 MG has ranged from a low of $3.1040 (Aug 23, 2023) to a high of $8.3904 (Nov 12, 2014), with a median of $5.2743 per EA.

Are there cheaper alternatives to OLANZAPINE-FLUOXETINE 3-25 MG?

No other NADAC-published product currently shares the active ingredient and strength of OLANZAPINE-FLUOXETINE 3-25 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OLANZAPINE-FLUOXETINE 3-25 MG?

OLANZAPINE-FLUOXETINE 3-25 MG (NDC 49884027711) is labeled by Endo USA Inc., and CMS classifies it as a generic product.